Cargando…

Serum vascular endothelial growth factor as a marker for tubal pregnancy

OBJECTIVE: The objective of this study was to evaluate whether a single measurement of vascular endothelial growth factor could distinguish between intrauterine pregnancy and ectopic pregnancy and to correlate the levels of vascular endothelial growth factor with serum levels of progesterone andβ-hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabar, Fábio Roberto, Pereira, Pedro Paulo, de Oliveira, Matheus Abelo, Francisco, Rossana Pulcinelli Vieira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575910/
https://www.ncbi.nlm.nih.gov/pubmed/35766702
http://dx.doi.org/10.1590/1806-9282.20220224
_version_ 1784811417157763072
author Cabar, Fábio Roberto
Pereira, Pedro Paulo
de Oliveira, Matheus Abelo
Francisco, Rossana Pulcinelli Vieira
author_facet Cabar, Fábio Roberto
Pereira, Pedro Paulo
de Oliveira, Matheus Abelo
Francisco, Rossana Pulcinelli Vieira
author_sort Cabar, Fábio Roberto
collection PubMed
description OBJECTIVE: The objective of this study was to evaluate whether a single measurement of vascular endothelial growth factor could distinguish between intrauterine pregnancy and ectopic pregnancy and to correlate the levels of vascular endothelial growth factor with serum levels of progesterone andβ-human chorionic gonadotropin in each subgroup. METHODS: Ninety patients with a positive human chorionic gonadotropin test and either abdominal pain or vaginal bleeding were selected; pregnancies were singletons, spontaneously conceived, 42–56 days of gestational age. All patients had a transvaginal ultrasound examination and were divided into three subgroups: abnormal intrauterine pregnancy, tubal pregnancy, and normal intrauterine pregnancy. Tubal pregnancies were surgically treated and histologically confirmed. Blood samples were collected for the determination of β-human chorionic gonadotropin, progesterone, and vascular endothelial growth factor and their concentrations were compared in each subgroup. Receiver operating characteristic curve was calculated by comparing the subgroup of tubal pregnancy to the other groups. A Fisher discriminant function analysis was performed. The level of significance was 5%. RESULTS: One-way analysis of variance revealed a significant correlation between the different subgroups and β-human chorionic gonadotropin, progesterone, and vascular endothelial growth factor serum levels (p<0.001). Vascular endothelial growth factor concentration was significantly higher for patients with tubal pregnancy than for other subgroups (p<0.05). β-Human chorionic gonadotropin and progesterone levels were higher in the subgroup with normal intrauterine pregnancies compared with the subgroups with tubal and abnormal intrauterine pregnancies (p<0.05). Serum vascular endothelial growth factor level >188.7 ng/mL predicted tubal pregnancy with 96.7% sensitivity, 95.0% specificity, 90.6% positive predictive value, and 98.3% negative predictive value. CONCLUSIONS: Serum vascular endothelial growth factor could be a marker in discriminating intrauterine pregnancy from tubal pregnancy; its levels are increased in women with ectopic pregnancy compared with women with normal and abnormal intrauterine pregnancies.
format Online
Article
Text
id pubmed-9575910
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Associação Médica Brasileira
record_format MEDLINE/PubMed
spelling pubmed-95759102022-10-19 Serum vascular endothelial growth factor as a marker for tubal pregnancy Cabar, Fábio Roberto Pereira, Pedro Paulo de Oliveira, Matheus Abelo Francisco, Rossana Pulcinelli Vieira Rev Assoc Med Bras (1992) Original Article OBJECTIVE: The objective of this study was to evaluate whether a single measurement of vascular endothelial growth factor could distinguish between intrauterine pregnancy and ectopic pregnancy and to correlate the levels of vascular endothelial growth factor with serum levels of progesterone andβ-human chorionic gonadotropin in each subgroup. METHODS: Ninety patients with a positive human chorionic gonadotropin test and either abdominal pain or vaginal bleeding were selected; pregnancies were singletons, spontaneously conceived, 42–56 days of gestational age. All patients had a transvaginal ultrasound examination and were divided into three subgroups: abnormal intrauterine pregnancy, tubal pregnancy, and normal intrauterine pregnancy. Tubal pregnancies were surgically treated and histologically confirmed. Blood samples were collected for the determination of β-human chorionic gonadotropin, progesterone, and vascular endothelial growth factor and their concentrations were compared in each subgroup. Receiver operating characteristic curve was calculated by comparing the subgroup of tubal pregnancy to the other groups. A Fisher discriminant function analysis was performed. The level of significance was 5%. RESULTS: One-way analysis of variance revealed a significant correlation between the different subgroups and β-human chorionic gonadotropin, progesterone, and vascular endothelial growth factor serum levels (p<0.001). Vascular endothelial growth factor concentration was significantly higher for patients with tubal pregnancy than for other subgroups (p<0.05). β-Human chorionic gonadotropin and progesterone levels were higher in the subgroup with normal intrauterine pregnancies compared with the subgroups with tubal and abnormal intrauterine pregnancies (p<0.05). Serum vascular endothelial growth factor level >188.7 ng/mL predicted tubal pregnancy with 96.7% sensitivity, 95.0% specificity, 90.6% positive predictive value, and 98.3% negative predictive value. CONCLUSIONS: Serum vascular endothelial growth factor could be a marker in discriminating intrauterine pregnancy from tubal pregnancy; its levels are increased in women with ectopic pregnancy compared with women with normal and abnormal intrauterine pregnancies. Associação Médica Brasileira 2022-06-24 /pmc/articles/PMC9575910/ /pubmed/35766702 http://dx.doi.org/10.1590/1806-9282.20220224 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Cabar, Fábio Roberto
Pereira, Pedro Paulo
de Oliveira, Matheus Abelo
Francisco, Rossana Pulcinelli Vieira
Serum vascular endothelial growth factor as a marker for tubal pregnancy
title Serum vascular endothelial growth factor as a marker for tubal pregnancy
title_full Serum vascular endothelial growth factor as a marker for tubal pregnancy
title_fullStr Serum vascular endothelial growth factor as a marker for tubal pregnancy
title_full_unstemmed Serum vascular endothelial growth factor as a marker for tubal pregnancy
title_short Serum vascular endothelial growth factor as a marker for tubal pregnancy
title_sort serum vascular endothelial growth factor as a marker for tubal pregnancy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575910/
https://www.ncbi.nlm.nih.gov/pubmed/35766702
http://dx.doi.org/10.1590/1806-9282.20220224
work_keys_str_mv AT cabarfabioroberto serumvascularendothelialgrowthfactorasamarkerfortubalpregnancy
AT pereirapedropaulo serumvascularendothelialgrowthfactorasamarkerfortubalpregnancy
AT deoliveiramatheusabelo serumvascularendothelialgrowthfactorasamarkerfortubalpregnancy
AT franciscorossanapulcinellivieira serumvascularendothelialgrowthfactorasamarkerfortubalpregnancy